195 related articles for article (PubMed ID: 10845392)
1. Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.
Korshunov A; Sycheva R; Timirgaz V; Golanov A
J Neurooncol; 1999; 45(3):219-27. PubMed ID: 10845392
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer.
Monden N; Abe S; Sutoh I; Hishikawa Y; Kinugasa S; Nagasue N
Oncology; 1997; 54(5):391-9. PubMed ID: 9260601
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of localization and grading in intracranial ependymomas of childhood.
Ernestus RI; Schröder R; Stützer H; Klug N
Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366
[TBL] [Abstract][Full Text] [Related]
6. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
8. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
9. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases.
Korshunov A; Golanov A; Timirgaz V
Acta Neuropathol; 2001 Sep; 102(3):271-7. PubMed ID: 11585252
[TBL] [Abstract][Full Text] [Related]
10. Nestin expression identifies ependymoma patients with poor outcome.
Milde T; Hielscher T; Witt H; Kool M; Mack SC; Deubzer HE; Oehme I; Lodrini M; Benner A; Taylor MD; von Deimling A; Kulozik AE; Pfister SM; Witt O; Korshunov A
Brain Pathol; 2012 Nov; 22(6):848-60. PubMed ID: 22568867
[TBL] [Abstract][Full Text] [Related]
11. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
12. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
13. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290
[TBL] [Abstract][Full Text] [Related]
14. The clinical and prognostic relevance of grading in intracranial ependymomas.
Ernestus RI; Schröder R; Stützer H; Klug N
Br J Neurosurg; 1997 Oct; 11(5):421-8. PubMed ID: 9474274
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
Kutlik MT; Ayhan A; Göğüş S; Yalçin B; Cağlar M; Büyükpamukçu M
Pediatr Hematol Oncol; 2002; 19(5):337-45. PubMed ID: 12078865
[TBL] [Abstract][Full Text] [Related]
16. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
17. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
18. A multi-center retrospective analysis of treatment effects and quality of life in adult patients with cranial ependymomas.
Dützmann S; Schatlo B; Lobrinus A; Murek M; Wostrack M; Weiss C; Schaller K; Raabe A; Meyer B; Goldbrunner R; Franz K; Seifert V; Senft C
J Neurooncol; 2013 Sep; 114(3):319-27. PubMed ID: 23813228
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
Rudà R; Bosa C; Magistrello M; Franchino F; Pellerino A; Fiano V; Trevisan M; Cassoni P; Soffietti R
Neuro Oncol; 2016 Feb; 18(2):261-8. PubMed ID: 26323606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
